Zielgerichtete Therapie bei BRAF-mutiertem metastasierten papillären Schilddrüsenkarzinom und malignen Melanom (2019) Bender-Säbelkampf S, Tüting T, Alter M, Horbrügger M Conference contribution, Abstract of a poster Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma (2019) Naoum C, Majenka P, Loquai C, Kaehler K, Heinzerling L, Dudda M, Hassel J Conference contribution Multicentric Sentinel Healthcare Research Project of Skin Cancer Centers in Nuremberg, Erlangen, Regensburg and Wuerzburg (2019) Enzelsberger K, Debus D, Schultz E, Haferkamp S, Hegemann MV, Stolze I, Erdmann M, Schellerer V Conference contribution ECP as prognostic Marker for Melanoma (2019) Moreira A, Krueckel A, Schuler G, Utikal J, Heinzerling L Conference contribution Blood eosinophilia is an on-treatment biomarker in patients undergoing vaccination with dendritic cells that correlates with long-term patient outcome (2019) Moreira A, Vass V, Erdmann M, Sponagl F, Schuler G, Schuler-Thurner B Conference contribution Do Patients with Lower Limb Melanoma have an increased Risk of a "false negative" Sentinel Node Biopsy? (2019) Braun L, Schellerer V, Schuler G, Goeol J, Erdmann M Conference contribution